Unichem Laboratories Limited has received ANDA approval for its Apremilast Tablets, 10 mg, 20 mg and 30 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Amgen's Otezla® (apremilast) Tablets, 10 mg, 20 mg, and 30 mg.
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Shares of UNICHEM LABORATORIES LTD. was last trading in BSE at Rs.306 as compared to the previous close of Rs. 306.35. The total number of shares traded during the day was 4756 in over 193 trades.
The stock hit an intraday high of Rs. 309 and intraday low of 302.85. The net turnover during the day was Rs. 1457975.